Amie T Kron1, Allison Collins2, Christine Cserti-Gazdewich3,4, Jacob Pendergrast3,4, Kathryn Webert5,6, Lani Lieberman3,4, Michelle P Zeller5,7, Sheila R Harding8, Susan Nahirniak9,10, Oksana Prokopchuk-Gauk8, Yulia Lin1,3, Brent Mendez9,10, Chantal Armali1, Christina Lee11, Danielle Watson12, Dena Arnott13, Fengju Xun1,14, Heather Blain9, Heather Panchuk8, Hertha Hughes15, Kathy Chorneyko16, Michael Angers17, Nicole Pilutti18, Ryan Lett13, Shauna Dowsley11, Theodora Ruijs19, Tracy Cupido20, Tracy Kichinko16, Troy Thompson2, Zohreh Afshar-Ghotli12, Jeannie Callum1,3. 1. Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 2. Ontario Regional Blood Coordinating Network (ORBCoN), Toronto, Ontario, Canada. 3. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. 4. Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. 5. Canadian Blood Services, Ottawa, Ontario, Canada. 6. Department of Molecular Medicine and Pathology, McMaster University, Hamilton, Ontario, Canada. 7. Department of Medicine, McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada. 8. Department of Laboratory Medicine and Pathology, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada. 9. Department of Laboratory Medicine and Pathology, Alberta Precision Laboratories, Grande Prairie, Alberta, Canada. 10. Department of Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. 11. Department of Laboratory Medicine and Genetics Program, Trillium Health Partners, Mississauga, Ontario, Canada. 12. Department of Transfusion Medicine, Laboratory Services, Grey Bruce Health Services, Owen Sound, Ontario, Canada. 13. Department of Laboratory Medicine and Pathology, Saskatchewan Health Authority, Regina, Saskatchewan, Canada. 14. Human Biology Program, Faculty of Arts and Science, University of Toronto, Toronto, Ontario, Canada. 15. Department of Laboratory Medicine, Quinte Healthcare Corporation, Belleville, Ontario, Canada. 16. Department of Laboratory Services, Brant Community Healthcare System, Brantford, Ontario, Canada. 17. Laboratory Medicine Program, Lakeridge Health, Ajax, Ontario, Canada. 18. Department of Laboratory Services, Windsor Regional Hospital, Windsor, Ontario, Canada. 19. Department of Pathology, William Osler Health System, Brampton, Ontario, Canada. 20. Department of Anesthesiology, Quinte Healthcare Corporation, Belleville, Ontario, Canada.
Abstract
BACKGROUND: Transfusion of red blood cells (RBC) is a common procedure, which when prescribed inappropriately can result in adverse patient outcomes. This study sought to determine the impact of a multi-faceted intervention on unnecessary RBC transfusions at hospitals with a baseline appropriateness below 90%. STUDY DESIGN AND METHODS: A prospective medical chart audit of RBC transfusions was conducted across 15 hospitals. For each site, 10 RBCs per month transfused to inpatients were audited for a 5-month pre- and 10-month post-intervention period, with each transfusion adjudicated for appropriateness based on pre-set criteria. Hospitals with appropriateness rates below 90% underwent a 3-month intervention which included: adoption of standardized RBC guidelines, staff education, and prospective transfusion order screening by blood bank technologists. Proportions of RBC transfusions adjudicated as appropriate and the total number of RBC units transfused per month in the pre- and post-intervention period were examined. RESULTS: Over the 15-month audit period, at the 13 hospital sites with a baseline appropriateness below 90%, 1950 patients were audited of which 81.2% were adjudicated as appropriate. Proportions of appropriateness and single-unit orders increased from 73.5% to 85% and 46.2% to 68.2%, respectively from pre- to post-intervention (P < .0001). Pre- and post-transfusion hemoglobin levels and the total number of RBCs transfused decreased from baseline (P < .05). The median pre-transfusion hemoglobin decreased from a baseline of 72.0 g/L to 69.0 g/L in the post-intervention period (P < .0001). RBC transfusions per acute inpatient days decreased significantly in intervention hospitals, but not in control hospitals (P < .001). The intervention had no impact on patient length of stay, need for intensive care support, or in-hospital mortality. CONCLUSION: This multifaceted intervention demonstrated a marked improvement in RBC transfusion appropriateness and reduced overall RBC utilization without impacts on patient safety.
BACKGROUND: Transfusion of red blood cells (RBC) is a common procedure, which when prescribed inappropriately can result in adverse patient outcomes. This study sought to determine the impact of a multi-faceted intervention on unnecessary RBC transfusions at hospitals with a baseline appropriateness below 90%. STUDY DESIGN AND METHODS: A prospective medical chart audit of RBC transfusions was conducted across 15 hospitals. For each site, 10 RBCs per month transfused to inpatients were audited for a 5-month pre- and 10-month post-intervention period, with each transfusion adjudicated for appropriateness based on pre-set criteria. Hospitals with appropriateness rates below 90% underwent a 3-month intervention which included: adoption of standardized RBC guidelines, staff education, and prospective transfusion order screening by blood bank technologists. Proportions of RBC transfusions adjudicated as appropriate and the total number of RBC units transfused per month in the pre- and post-intervention period were examined. RESULTS: Over the 15-month audit period, at the 13 hospital sites with a baseline appropriateness below 90%, 1950 patients were audited of which 81.2% were adjudicated as appropriate. Proportions of appropriateness and single-unit orders increased from 73.5% to 85% and 46.2% to 68.2%, respectively from pre- to post-intervention (P < .0001). Pre- and post-transfusion hemoglobin levels and the total number of RBCs transfused decreased from baseline (P < .05). The median pre-transfusion hemoglobin decreased from a baseline of 72.0 g/L to 69.0 g/L in the post-intervention period (P < .0001). RBC transfusions per acute inpatient days decreased significantly in intervention hospitals, but not in control hospitals (P < .001). The intervention had no impact on patient length of stay, need for intensive care support, or in-hospital mortality. CONCLUSION: This multifaceted intervention demonstrated a marked improvement in RBC transfusion appropriateness and reduced overall RBC utilization without impacts on patient safety.
Authors: Eric McGinnis; Robert J Guo; Krista M Marcon; Brian Berry; Robert Coupland; Victor Meneghetti; Douglas Morrison; Rodrigo Onell; Lisa Steele; Jacqueline Trudeau; Michelle Wong; Andrew W Shih Journal: Transfusion Date: 2021-01-16 Impact factor: 3.337